Sherry Korczynski's most recent trade in Aquestive Therapeutics Inc was a trade of 25,000 Common Stock done . Disclosure was reported to the exchange on Aug. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Sherry Korczynski | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 25,000 | 181,858 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Sherry Korczynski | SVP Sales and Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.54 per share. | 09 Jun 2025 | 2,714 | 156,858 (0%) | 0% | 3.5 | 9,608 | Common Stock |
| Aquestive Therapeutics Inc | Sherry Korczynski | SVP Sales and Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 90,000 | 165,000 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Sherry Korczynski | SVP Sales and Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 35,000 | 35,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Sherry Korczynski | SVP Sales and Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 5,428 | 159,572 (0%) | 0% | 2.6 | 14,384 | Common Stock |
| Aquestive Therapeutics Inc | Sherry Korczynski | SVP Sales and Marketing | 07 Jun 2024 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock |